Cuban-developed vaccine enters Phase III trial

  • 📰 ABSCBNNews
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 83%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

The Cuban-developed coronavirus candidate vaccine named Soberana 2 is a recombinant protein vaccine. Recombinant vaccines, unlike some coronavirus shots already in use, do not need extreme refrigeration.

A Cuban-developed coronavirus candidate vaccine entered into Phase III trials Thursday, the first shot developed by a Latin American country to get this far, the government said.

This third phase of the trial will officially end three months after the last dose is injected, the institute's Yury Valdes told reporters.The communist state, which has stated it wants to vaccinate all inhabitants this year, has been relatively unscathed by the Covid-19 pandemic, with just over 53,300 recorded cases and 336 deaths in a population of 11.2 million.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 5. in LAW

Law Law Latest News, Law Law Headlines